Dysregulation of miR-31 and miR-21 Induced by Zinc Deficiency Promotes Esophageal Cancer
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INTRODUCTION

Figure 1. Normal ZS organs display high abundance of tissue-speciﬁc microRNAs.

Figure 2. ZD induces distinct microRNA expression patterns in a wide variety of tissues.

miR-31 ISH signal (blue, NBT/BCIP, arrowheads) was strong/abundant in esophageal/tongue epithelia
of ZD vs ZS tissues, miR-21 signal (blue, arrows) moderate in basal/stromal cells in ZD vs ZS tissues.
mm-miR-31 or mm-miR-21 (2 mismatches) had no ISH signals. Scale bar, 25 μm.

( A) Serum and tissue Zn content. (B) qRT-PCR analysis of 8 inﬂammation genes (normalized to PSMB6)
(ZD vs ZS, *P<0.05, **P<0.01, ***P<0.001). (C, D) Expression of inﬂammation proteins: immunoblot (S100A8
and S100A9); ELISA assay (CXCL5 and IL1B).

Table 2. Gene ontology (GO) enrichment analysis of the microRNA target genes
in Zn-deﬁcient tissues.
ZD Tissue

(A) IHC shows reduction of PDCD4 (target of miR-21) nuclear expression in ZD esophagus/tongue vs ZS tissues.
(B) Immunoblots show downregulation of PDCD4 and TPM1 (targets of miR-21), RHOBTB1, STAU2, and
PPP2R2A (targets of miR-31) in ZD esophagus/tongue vs ZS tissues.

Figure 6. Correlation of miR-31 and miR-21 expression and ESCC outcome in
Zn-modulated rats3.
(A) Heat maps showing supervised clustering of miRNA expression in 7 tissues (n=6 rats/dietary group/tissue,
P<0.05). (B) Barplots showing fold-change of miRNA expression in ZD vs ZS tissues (P< 0.05, fold change ≥ 1.3).

Figure 3. Taqman miRNA assay validates nanoString data.

TaqMan miRNA assay: Pre-designed probes and U87 (normalizer) were from
Applied Biosystems, and the comparative Ct method was used.

In situ hybridization (ISH): FFPE sections were hybridized with double
DIG-labeled locked nucleic acid (LNA) detection probes: antimiR-31,
antimiR-21 or mismatch probes (Exiqon) in hybridization buffer (57ºC for
14 h). The sections were then blocked against unspecific binding of the
detecting antibody. miRNA was localized by incubation with 4-nitro-blue
tetrazolium (NBT) and 5-brom-4-chloro-3-indolylphosphate (BCIP), and
counterstained by nuclear fast red.

Immunohistochemistry (IHC): PDCD4 (LS-B1388, Lifespan Biosciences) IHC
was performed on FFPE sections after antigen retrieval3.

Immunoblot Analysis: Protein samples were separated by SDS-polyacrylamide

gel electrophoresis. The primary antibodies used were: PDCD4, TPM1
(ab55915; Abcam), PPP2R2A (#5689, Cell Signaling). RHOBTB1 (sc-102084;
Santa Cruz Biotech), STAU2 (sc-87439; Santa Cruz Biotech). Immuno
-detection was by Pierce enhanced chemiluminescence substrate.
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Study design: Male weanling Sprague-Dawley rats were fed an egg
white-based ZD or Zn-sufficient (ZS) diet for 23 weeks1. Blood, esophagus,
tongue, skin, lung, liver, prostate, and pancreas were collected. Esophagus
and tongue were cut into two portions: one portion was formalin-fixed and
paraffin-embedded (FFPE) and the other snap-frozen and stored at -80ºC.

Gene ontology (GO) analysis: For each miRNA, the common target genes
found in >2 databases (RNAhybrid, TargetScan, miRDB and microRNA.org)
were used. GO analysis was performed using Database for Annotation,
Visualization and Integrated Discovery (DAVID).

Esophagus

Lung

METHODS

miRNA expression profiling: The nanoString nCounter system (nanoString
Technologies) that directly measures miRNA expression levels without
enzymatic reactions or bias was used. Total RNA (100 ng) was the input
material. Small RNA samples were prepared by ligating a specific DNA tag
onto the 3’ end of each mature miRNA. The tags provided identification for
each miRNA species in the sample. Following hybridization with a panel of
miRNA:tag-specific nCounter capture and barcoded reporter probes, the
hybridized probes were immobilized on a streptavidin-coated cartridge.
Fluorescent barcodes and target RNA molecules were quantified and a
high-density scan was performed. Each sample was normalized to the
geometric mean of 50 most highly expressed miRNAs. Statistical
significances of pair-wise comparisons were calculated by student’s t-test.

Figure 8. Prolonged ZD (23 weeks) reduces tissue Zn content and induces
overexpression of inﬂammation markers.

Figure 5. Overexpression of miR-31 and miR-21 is associated with downregulation
of their tumor-suppressor targets.

Our ZD rat tumor model that reproduces the ZD link to human ESCC provides
an opportunity to decipher the mechanism by which ZD promotes ESCC.
Previously, we showed that weanling rats on a ZD diet for 6 weeks developed
a precancerous upper aerodigestive tract (tongue, esophagus, and forestomach [expanded lower esophagus]), with increased cellular proliferation
and extensive gene expression changes, including overexpression of
proinflammation-genes S100a8 and S100a9 2. Prolonged ZD (~21 weeks)
amplified this inflammation by causing overexpression of numerous
inflammation genes in addition to S100a8/S100a9, thereby providing an
inflammatory microenvironment conducive to ESCC development upon
repeated exposure to an environmental carcinogen. Zn-replenishment (ZR)
reversed the inflammatory signature and prevented cancer formation3.
In nutritionally complete rats, Zn-supplementation suppressed tongue SCC
development by attenuating inflammation4.

Here we investigated whether overexpression of cancer-related inflammation
genes induced by ZD in the esophagus3 is a consequence of a protumorigenic
microRNA signature. We examined miRNA profiles in esophagus and six other
tissues (skin, lung, pancreas, liver, prostate, peripheral blood mononuclear
cells [PBMC]) after prolonged ZD, using the nanoString nCounter technology8,9.

Figure 4. miR-31 and miR-21 overexpression in precancerous ZD esophagus/tongue
is cell type speciﬁc.

ZS organs show high abundance of liver-speciﬁc miR-122 in liver; skin-speciﬁc miR-203 in skin; epitheliaspeciﬁc miR-205 in skin and esophagus; pancreas-speciﬁc miR-375, miR-216, miR-217 in pancreas;
hematopoietic markers miR-142-3p, miR-150, miR-16, miR191, miR-26a, miR-19b in PBMC. These data
establish that nanoString system is sensitive and speciﬁc.

ESCC is a deadly cancer with a 5-year survival of ~10%. The major risk factors
are alcohol consumption, tobacco use, and nutritional deficiencies, including
ZD. Zn is an essential trace element required for the activity of >300 enzymes,
for proper immune function, and for the conformation of >2000 transcription
factors that control cell proliferation, apoptosis, and signaling pathways.
ZD predisposes to diseases by adversely affecting these processes.

microRNAs (miRNAs) are small non-coding RNAs that have emerged as
powerful posttranscriptional regulators of gene expression. The ability of
individual miRNAs to regulate a large number of mRNA species allows
them to coordinate complex programs of gene expression that alter critical
biological processes such as proliferation, apoptosis, and signaling events5.
miRNAs expression levels are altered in many human cancers6 and chronic
inflammatory diseases/conditions7.
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RESULTS

ABSTRACT
Dietary zinc (Zn) deficiency (ZD) in rats induces an inflammatory
gene signature that fuels esophageal squamous cell cancer (ESCC).
Using nanoStringTM technology, we show that the inflammation is
accompanied by altered expression of specific microRNAs in
esophagus, as well as skin, lung, pancreas, liver, prostate, and
PBMC, predictive of disease development. Particularly, the ZD
esophagus has a microRNA signature resembling human
ESCC/tongue SCC miRNAomes with overexpression of miR-31 and
miR-21 and downregulation of their respective tumor suppressor
targets PPP2R2A and PDCD4. Esophageal miR-31 and miR-21 levels
are directly associated with the appearance of ESCC. In situ
hybridization localizes miR-31 to tumor and miR-21 to stromal cells,
establishing their cell-type specificity. In regressing tongue SCCs
from Zn-supplemented rats, miR-31 and miR-21 expression was
concomitantly reduced, establishing their responsiveness to
Zn-therapy. A search for putative microRNA targets revealed a
bias toward genes in inflammatory pathways. Thus, ZD induces
inflammation-associated microRNAs and promotes ESCC1.
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TaqMan miRNA assay validates 14 representative miRNAs in ZD tissues and establishes upregulation of
miR-31 and miR-21 in ZD tongue.

(A) Taqman miRNA assay: miR-31 and miR-21 expression levels are 5.4 and 3.2-fold higher in ESCC-bearing
ZD esophagi vs cancer-free ZS controls. ZR that prevented ESCC development3 reduces miR-31 and miR-21
expression to ZS levels. (B) ISH assay: strong/abundant miR-31 signal (blue, NBT/BCIP, arrowheads) in
tumor and miR-21 signal (blue, arrows) in stroma of ESCC from a ZD rat; weak/absent miR-31/miR21 signals in
ZS and ZR esophageal samples.

Table 1. ZD rat tissues show dysregulated oncogenic/tumor suppressor microRNAs
that are aberrantly expressed in various human diseases.

Figure 7. miR-31 and miR-21 expression in tongue SCCs is responsive to Zn-therapy.

ZD skin (Psoriasis)
: miR-31, miR-21, miR-142-3p
ZD lung (COPD/Human lung cancer)
: miR-223, miR-451, miR-15b, miR-21
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CONCLUSIONS
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